{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:40:16Z","timestamp":1782297616733,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1136\/ard.2008.092619","type":"journal-article","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T00:54:10Z","timestamp":1218675250000},"page":"1265-1270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Opportunities for improving medication use and monitoring in gout"],"prefix":"10.1016","volume":"68","author":[{"given":"J A","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J S","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"Asch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2008.092619_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/art.20405","article-title":"A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy","volume":"51","author":"Shoji","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092619_bib2","first-page":"562","article-title":"Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internet-accessible error reporting system","volume":"33","author":"Mikuls","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.092619_bib3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/rheumatology\/keh679","article-title":"Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD)","volume":"44","author":"Mikuls","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2008.092619_bib4","first-page":"104","article-title":"Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study","volume":"33","author":"Neogi","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.092619_bib5","first-page":"346","article-title":"A survey of allopurinol dosage prescribing","volume":"108","author":"McClintock","year":"1995","journal-title":"N Z Med J"},{"key":"10.1136\/ard.2008.092619_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1440-1762.2000.00353.x","article-title":"Quality use of allopurinol in the elderly","volume":"20","author":"Smith","year":"2000","journal-title":"J Qual Clin Pract"},{"issue":"(9 Suppl","key":"10.1136\/ard.2008.092619_bib7","first-page":"S401","article-title":"Patient reported outcomes assoicated with gout: baseline results from two clinical trials","volume":"52","author":"Osterhaus","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092619_bib8","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.092619_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.57.9.545","article-title":"Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout","volume":"57","author":"Perez-Ruiz","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092619_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.rhu.0000209882.50228.9f","article-title":"Serum urate levels and gout flares: analysis from managed care data","volume":"12","author":"Sarawate","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/ard.2008.092619_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2125.1988.tb03401.x","article-title":"Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion","volume":"26","author":"Day","year":"1988","journal-title":"Br J Clin Pharmacol"},{"issue":"(9 Suppl","key":"10.1136\/ard.2008.092619_bib12","first-page":"S410","article-title":"Ability to attain target serum uric acid level in gout patients on allopurinol","volume":"52","author":"Yang","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092619_bib13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/art.20102","article-title":"Quality of care indicators for gout management","volume":"50","author":"Mikuls","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092619_bib14","first-page":"1246","article-title":"Intermittent control of hyperuricemia in the treatment of gout","volume":"16","author":"Bull","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.092619_bib15","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.092619_bib16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","article-title":"Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout","volume":"52","author":"Becker","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092619_bib17","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","article-title":"Clinical practice. Gout","volume":"349","author":"Terkeltaub","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.092619_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0049-0172(82)90065-8","article-title":"The efficacy of colchicine prophylaxis in articular gout: a reappraisal after 20 years","volume":"12","author":"Yu","year":"1982","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2008.092619_bib19","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092619_bib20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.22767","article-title":"Quality of care for gout in the US needs improvement","volume":"57","author":"Singh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092619_bib21","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/ard.2006.051649","article-title":"Sex differences in gout epidemiology: evaluation and treatment","volume":"65","author":"Harrold","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092619_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4065\/81.7.925","article-title":"Gout medication treatment patterns and adherence to standards of care from a managed care perspective","volume":"81","author":"Sarawate","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1136\/ard.2008.092619_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/ard.2007.076182","article-title":"Uric acid lowering therapy: prescribing patterns in a large cohort of older adults","volume":"67","author":"Solomon","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092619_bib24","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2007.081604","article-title":"Gout is associated with more comorbidities, poorer health related quality of life and higher health care utilization in US veterans","volume":"67","author":"Singh","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092619_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1136\/ard.2008.092619_bib26","author":"Bennett","year":"1987","journal-title":"Drug prescribing in renal failure"},{"key":"10.1136\/ard.2008.092619_bib27","first-page":"495","article-title":"Review: systemic toxicity associated with the intravenous administration of colchicine\u2014guidelines for use","volume":"15","author":"Wallace","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.092619_bib28","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1200\/JCO.1987.5.9.1469","article-title":"Compliance with oral drug therapy in patients with hematologic malignancy","volume":"5","author":"Levine","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1136\/ard.2008.092619_bib29","doi-asserted-by":"crossref","first-page":"938","DOI":"10.7326\/0003-4819-141-12-200412210-00010","article-title":"Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample","volume":"141","author":"Asch","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.092619_bib30","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMsa021899","article-title":"Effect of the transformation of the Veterans Affairs Health Care System on the quality of care","volume":"348","author":"Jha","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.092619_bib31","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.284.8.984","article-title":"Quality of care for patients with rheumatoid arthritis","volume":"284","author":"MacLean","year":"2000","journal-title":"JAMA"},{"key":"10.1136\/ard.2008.092619_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCULATIONAHA.105.505636","article-title":"Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease","volume":"113","author":"Newby","year":"2006","journal-title":"Circulation"},{"key":"10.1136\/ard.2008.092619_bib33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"key":"10.1136\/ard.2008.092619_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-55-2-179","article-title":"Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects","volume":"55","author":"Yu","year":"1961","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.092619_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199602153340707","article-title":"The management of gout","volume":"334","author":"Emmerson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.092619_bib36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7326\/0003-4819-141-4-200408170-00007","article-title":"Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study","volume":"141","author":"Kerr","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.092619_bib37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.291.3.335","article-title":"Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes","volume":"291","author":"Saydah","year":"2004","journal-title":"JAMA"},{"key":"10.1136\/ard.2008.092619_bib38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0002-9149(02)02739-X","article-title":"Practice patterns related to the Adult Treatment Panel III guidelines in primary care","volume":"90","author":"Eaton","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1136\/ard.2008.092619_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/hc0202.101971","article-title":"New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population","volume":"105","author":"Fedder","year":"2002","journal-title":"Circulation"},{"key":"10.1136\/ard.2008.092619_bib40","first-page":"1146","article-title":"Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative","volume":"9","author":"Hoekstra","year":"2002","journal-title":"Acad Emerg Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724216800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724216800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2008.092619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T15:34:47Z","timestamp":1736091287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724216800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0003496724216800"],"URL":"https:\/\/doi.org\/10.1136\/ard.2008.092619","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opportunities for improving medication use and monitoring in gout","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2008.092619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 2009 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}